New-onset acute heart failure and ventricular tachycardia after therapy with a tumor necrosis factor antagonist.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 15895906)

Published in Clin Exp Rheumatol on May 17, 2005

Authors

J F Boyer, B Jamard, S El Mahou, M Laroche, B Mazières, A Cantagrel, A Constantin

Articles by these authors

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis (2008) 6.97

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis (2003) 3.33

Twenty five year mortality and air pollution: results from the French PAARC survey. Occup Environ Med (2005) 3.07

Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.66

Stenosis of the lumbar spinal canal in vertebral ankylosing hyperostosis. Spine (Phila Pa 1976) (1992) 2.07

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06

Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum (2001) 2.00

Management of nontuberculous infectious discitis. treatments used in 110 patients admitted to 12 teaching hospitals in France. Joint Bone Spine (2001) 1.98

EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis (2009) 1.95

In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol (2000) 1.77

Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum (1998) 1.71

Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol (2004) 1.66

Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol (1998) 1.59

[Late myopathies located at the spinal muscles: a cause of acquired lumbar kyphosis in adults]. Rev Rhum Mal Osteoartic (1991) 1.59

Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol (1996) 1.56

Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum (1999) 1.50

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum (2010) 1.47

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44

Neurosensory adverse effects after phenylbutazone and misoprostol combined treatment. Lancet (1989) 1.39

[Should long-term corticosteroid treatment be given in rheumatoid arthritis?]. Rev Rhum Ed Fr (1993) 1.39

Lactose intolerance and osteoporosis in men. Rev Rhum Engl Ed (1995) 1.39

Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study. Ann Rheum Dis (2003) 1.32

Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis (2004) 1.29

Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis (2005) 1.27

Isolation from Candida albicans of a functional homolog of the Saccharomyces cerevisiae KRE1 gene, which is involved in cell wall beta-glucan synthesis. J Bacteriol (1991) 1.24

Morphological analyses of paraspinal muscles: comparison of progressive lumbar kyphosis (camptocormia) and narrowing of lumbar canal by disc protrusions. Neuromuscul Disord (1994) 1.20

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry. Ann Rheum Dis (2012) 1.16

First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence. Ann Rheum Dis (2005) 1.16

Radiological damage in patients with rheumatoid arthritis on sustained remission. Ann Rheum Dis (2006) 1.16

Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis (2001) 1.15

Developmental regulation of the synthesis of proteins encoded by stored mRNA in radish embryos. Plant Physiol (1984) 1.13

Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis (2005) 1.12

Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (2002) 1.10

Health status and health services utilization of Canada's immigrant and non-immigrant populations. Can Public Policy (2000) 1.09

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis (2012) 1.09

Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis Rheum (1998) 1.08

[Primary camptocormia is a para-vertebral myopathy]. Rev Rhum Ed Fr (1994) 1.06

Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care Res (Hoboken) (2012) 0.96

Measurement of the radiological hip joint space width. An evaluation of various methods of measurement. Osteoarthritis Cartilage (2001) 0.96

Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial. Osteoporos Int (2012) 0.94

Relevant change in radiological progression in patients with hip osteoarthritis. I. Determination using predictive validity for total hip arthroplasty. Rheumatology (Oxford) (2002) 0.93

Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease. Clin Exp Rheumatol (2003) 0.93

Sonography of the hypertrophied column of Bertin. AJR Am J Roentgenol (1986) 0.91

Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging (2008) 0.91

Association of common genetic variants with colorectal cancer risk in a Romanian sample. Chirurgia (Bucur) (2011) 0.91

[Iconography of Buschke Ollendorff syndrome: x ray computed tomography and nuclear magnetic resonance of osteopoikilosis]. Ann Dermatol Venereol (1989) 0.90

[Osteonecrosis: natural course and conservative therapy]. Orthopade (2000) 0.90

Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology. Ann Rheum Dis (2005) 0.90

Medical treatment of reflex sympathetic dystrophy. Hand Clin (1997) 0.90

New insights into the genetics of immune responses in rheumatoid arthritis. Tissue Antigens (2012) 0.90

Intensive combined therapy for previously untreated aggressive myeloma. Blood (1992) 0.90

[Coxarthroses due to ischemia. Ischemic coxarthropathy]. Rev Rhum Mal Osteoartic (1978) 0.90

Whole body and regional bone mineral density in ankylosing spondylitis. J Rheumatol (2001) 0.90

Radiographic features predictive of radiographic progression of hip osteoarthritis. Rev Rhum Engl Ed (1997) 0.89

Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes. Clin Exp Immunol (1998) 0.89

Long-term mortality among adults with or without asthma in the PAARC study. Eur Respir J (2003) 0.89

[The hip in vertebral hyperostosis]. Rev Rhum Mal Osteoartic (1978) 0.89

Relevant change in radiological progression in patients with hip osteoarthritis. II. Determination using an expert opinion approach. Rheumatology (Oxford) (2002) 0.88

Q fever osteoarticular infection: four new cases and a review of the literature. Eur J Clin Microbiol Infect Dis (2007) 0.88

The recanalized umbilical vein in portal hypertension: a myth. AJR Am J Roentgenol (1985) 0.88

The effects of adding interruption to differential reinforcement on targeted and novel self-stimulatory behaviors. J Behav Ther Exp Psychiatry (1984) 0.87

Management of diabetic patients by general practitioners in France 1997: an epidemiological study. Diabetes Metab (2000) 0.87

Detection of sequences with Z-DNA forming potential in higher plants. Biochem Biophys Res Commun (1983) 0.87

Lumbar and cervical stenosis. Frequency of the association, role of the ankylosing hyperostosis. Clin Rheumatol (1992) 0.86

[Increase of CA 19.9 in dysimmune inflammatory rheumatism. Apropos of 6 cases]. Rev Rhum Ed Fr (1994) 0.86

Study of the intraosseous vessels of the femoral head in patients with fractures of the femoral neck or osteoarthritis of the hip. Osteoporos Int (1995) 0.86

Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study. Ann Rheum Dis (2007) 0.85

Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis. Clin Rheumatol (2006) 0.84

Absence of Epstein-Barr virus carrying cells in synovial membranes and subcutaneous nodules of patients with rheumatoid arthritis. Ann Rheum Dis (1993) 0.84

Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis (2011) 0.84

Normal FGF23 levels in adult idiopathic phosphate diabetes. Calcif Tissue Int (2009) 0.84

Pneumomediastinum, a rare complication of dermatomyositis. Report of a case. Rev Rhum Engl Ed (1996) 0.84

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Ann Rheum Dis (2010) 0.84

Cases of the day. General. Benign thymic cyst complicated by hemorrhage. Radiographics (1990) 0.84

A potential role for protein tyrosine kinase p56(lck) in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness. Int Immunol (2001) 0.83

Persistence of dominant T cell clones in synovial tissues during rheumatoid arthritis. J Immunol (1996) 0.83

[The association of B27 positive spondylarthritis with Klinefelter's syndrome]. Presse Med (1990) 0.83

Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. J Eur Acad Dermatol Venereol (2014) 0.83

Adhesive capsulitis of the shoulder: an open study of 40 cases treated by joint distention during arthrography followed by an intraarticular corticosteroid injection and immediate physical therapy. Rev Rhum Engl Ed (1998) 0.82

Increased vascularization in myeloma. Eur J Haematol (2001) 0.82

[End-stage renal failure following parathyroidectomy for advanced primary hyperparathyroidism]. Rev Med Interne (1998) 0.82

[Hyperostotic disease]. Rev Med Interne (1985) 0.82

Influence of the volume of osteonecrosis on the outcome of core decompression of the femoral head. Ann Rheum Dis (1997) 0.82